Clinical and Vaccine Immunology

期刊简介：Cessation. First launched as Clinical and Diagnostic Laboratory Immunology (CDLI) in 1994, CVI published articles that enhanced the understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology. CVI was committed to advancing all aspects of vaccine research and immunization, including discovery of new vaccine antigens and vaccine design, development and evaluation of vaccines in animal models and in humans, characterization of immune responses and mechanisms of vaccine action, controlled challenge studies to assess vaccine efficacy, study of vaccine vectors, adjuvants, and immunomodulators, immune correlates of protection, and clinical trials.

【译文】终止。CVI（临床和诊断实验室免疫学）首次于1994年推出，发表的文章增强了人们对健康和疾病以及疫苗接种后免疫反应的理解，通过展示临床、实验室和疫苗免疫学方面的发现。CVI致力于推进疫苗研究的各个方面和免疫接种，包括新疫苗抗原的发现和疫苗设计，动物模型和人类中疫苗的开发和评估，免疫反应和疫苗作用机制的表征，控制挑战研究以评估疫苗效力，研究疫苗载体、佐剂和免疫调节剂，免疫保护相关因素，以及临床试验。